rs200520956

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_021098.3(CACNA1H):ā€‹c.809A>Cā€‹(p.Asn270Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000603 in 1,596,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00034 ( 0 hom., cov: 32)
Exomes š‘“: 0.00063 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 3.15
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.060691893).
BP6
Variant 16-1200261-A-C is Benign according to our data. Variant chr16-1200261-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 460189.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000342 (52/152258) while in subpopulation NFE AF= 0.000544 (37/68000). AF 95% confidence interval is 0.000405. There are 0 homozygotes in gnomad4. There are 21 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 52 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1HNM_021098.3 linkuse as main transcriptc.809A>C p.Asn270Thr missense_variant 7/35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkuse as main transcriptc.809A>C p.Asn270Thr missense_variant 7/351 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000565831.6 linkuse as main transcriptc.809A>C p.Asn270Thr missense_variant 6/331 ENSP00000455840.1 O95180-2
CACNA1HENST00000638323.1 linkuse as main transcriptc.770A>C p.Asn257Thr missense_variant 7/355 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000639478.1 linkuse as main transcriptn.809A>C non_coding_transcript_exon_variant 7/355 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkuse as main transcriptn.809A>C non_coding_transcript_exon_variant 7/355 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.000342
AC:
52
AN:
152140
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000346
AC:
80
AN:
231174
Hom.:
0
AF XY:
0.000372
AC XY:
47
AN XY:
126254
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000123
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000145
Gnomad NFE exome
AF:
0.000683
Gnomad OTH exome
AF:
0.000352
GnomAD4 exome
AF:
0.000630
AC:
910
AN:
1444248
Hom.:
0
Cov.:
31
AF XY:
0.000592
AC XY:
424
AN XY:
716050
show subpopulations
Gnomad4 AFR exome
AF:
0.000152
Gnomad4 AMR exome
AF:
0.000140
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000194
Gnomad4 NFE exome
AF:
0.000782
Gnomad4 OTH exome
AF:
0.000436
GnomAD4 genome
AF:
0.000342
AC:
52
AN:
152258
Hom.:
0
Cov.:
32
AF XY:
0.000282
AC XY:
21
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.000217
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000544
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000507
Hom.:
1
Bravo
AF:
0.000363
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000475
AC:
4
ExAC
AF:
0.000432
AC:
52

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

CACNA1H-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesApr 24, 2023The CACNA1H c.809A>C variant is predicted to result in the amino acid substitution p.Asn270Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.068% of alleles in individuals of European (Non-Finnish) descent in gnomAD (https://gnomad.broadinstitute.org/variant/chr16-1250261-A-C). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 22, 2021The c.809A>C (p.N270T) alteration is located in exon 7 (coding exon 6) of the CACNA1H gene. This alteration results from a A to C substitution at nucleotide position 809, causing the asparagine (N) at amino acid position 270 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 27, 2023- -
not provided Benign:1
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
17
DANN
Benign
0.60
DEOGEN2
Benign
0.38
T;.;.;.
Eigen
Benign
-0.41
Eigen_PC
Benign
-0.31
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.80
T;T;T;.
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.061
T;T;T;T
MetaSVM
Uncertain
-0.11
T
MutationAssessor
Benign
0.70
N;.;N;N
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.34
N;.;N;N
REVEL
Benign
0.22
Sift
Benign
0.70
T;.;T;T
Sift4G
Benign
0.58
T;.;T;T
Polyphen
0.47
P;.;B;B
Vest4
0.41
MVP
0.84
ClinPred
0.021
T
GERP RS
0.88
Varity_R
0.045
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200520956; hg19: chr16-1250261; COSMIC: COSV62000394; COSMIC: COSV62000394; API